title: Lipitor kicks off onslaught of drug patent conversions.
authors.affiliation: TReinke@ManagedCareMag.com
authors.forename: Thomas
authors.initials: T
authors.lastname: Reinke
mesh_terms: D000069059:Atorvastatin; D016568:Drugs, Generic; D004465:Economic Competition; D006538:Heptanoic Acids / Q000627:therapeutic use; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D010330:Patents as Topic; D011758:Pyrroles / Q000627:therapeutic use; D014481:United States
chemical_list: D016568:Drugs, Generic; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin